Literature DB >> 11939169

Can't lung cancer patients detoxify procarcinogens?

K Cerrahoglu1, E Kunter, T Isitmangil, A I M Oztosun, G Isitmangil, O Okutan, E Bozkanat, R Aydilek, A Bener.   

Abstract

BACKGROUND: Glutathione S-transferase mu (GST mu) enzyme detoxifies carcinogens in tobacco smoke. We assessed the clinical usefulness of serum assay of GSTm in determining the risk for lung cancer.
MATERIALS AND METHODS: Fifty-nine patients with primary lung cancer and 32 control cases were enrolled. GSTm detection was performed by the method ELISA.
RESULTS: GSTm enzyme positivity rate of the patient group (39%) was significantly lower than the control group (59.4%) (p < 0.05). The GSTm positivity rates were 28.6% for the non-smoker patients with a cancer history of relatives, 31.6% for the smoker patients with the cancer history of relatives, 14.6% for the non-smoker patients with the lung cancer history of relatives and 16.7% for the smoker patients with the lung cancer history of relatives.
CONCLUSIONS: We concluded that if the people lacking GSTm are smokers and have a cancer and/or lung cancer history among their relatives, they would challenge a greater risk of lung cancer than the individuals having GST mu isoenzyme.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11939169

Source DB:  PubMed          Journal:  Allerg Immunol (Paris)        ISSN: 0397-9148


  1 in total

1.  The treatment of pulmonary diseases and respiratory-related conditions with inhaled (nebulized or aerosolized) glutathione.

Authors:  Jonathan Prousky
Journal:  Evid Based Complement Alternat Med       Date:  2008-03       Impact factor: 2.629

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.